Benzinga | Jul 30, 2020 12:37PM EDT

Needham Maintains Buy on Genocea Biosciences, Lowers Price Target to $7

Needham maintains Genocea Biosciences (NASDAQ:GNCA) with a Buy and lowers the price target from $10 to $7.